Hemorrhagic cystitis in a patient receiving gemtuzumab ozogamicin for relapsed acute promyelocytic leukemia after cord blood transplantation

被引：0
|
作者：
Akihide Yoshimi
Takashi Asai
Akira Hangaishi
Tsuyoshi Takahashi
Shigeru Chiba
Mineo Kurokawa
机构：
[1] University of Tokyo,Department of Hematology & Oncology, Graduate School of Medicine
来源：
Annals of Hematology | 2008年 / 87卷
关键词：
Herpes Simplex Virus; Hematopoietic Stem Cell Transplantation; Acute Promyelocytic Leukemia; Arsenic Trioxide; Gemtuzumab Ozogamicin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：851 / 852
页数：1
相关论文
共 50 条
  • [1] Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia
    Yamada, Yuji
    Osumi, Tomoo
    Kato, Motohiro
    Shioda, Yoko
    Kiyotani, Chikako
    Terashima, Keita
    Hayakawa, Akira
    Iijima-Yamashita, Yuka
    Horibe, Keizo
    Matsumoto, Kimikazu
    Tomizawa, Daisuke
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (04) : 178 - 180
  • [2] Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
    Azuma, Yoshiko
    Nakaya, Aya
    Hotta, Masaaki
    Fujita, Shinya
    Tsubokura, Yukie
    Yoshimura, Hideaki
    Satake, Atsushi
    Ishii, Kazuyoshi
    Ito, Tomoki
    Nomura, Shosaku
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 31 - 34
  • [3] Treatment of Relapsed Acute Promyelocytic Leukemia with Gemtuzumab Ozogamicin and All-Trans Retinoic Acid
    Tageja, N.
    Valent, J.
    Zonder, J.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (06) : 705 - 706
  • [4] Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia
    Huetter, Marie-Luise
    Schlenk, Richard F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (10) : 1369 - 1380
  • [5] Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
    Yamauchi, Takuji
    Mori, Yasuo
    Miyamoto, Toshihiro
    Kamezaki, Kenjiro
    Aoki, Takatoshi
    Yamamoto, Asataro
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Harada, Naoki
    Nagafuji, Koji
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (03) : 416 - 420
  • [6] Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
    Takuji Yamauchi
    Yasuo Mori
    Toshihiro Miyamoto
    Kenjiro Kamezaki
    Takatoshi Aoki
    Asataro Yamamoto
    Katsuto Takenaka
    Hiromi Iwasaki
    Naoki Harada
    Koji Nagafuji
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2009, 90 : 416 - 420
  • [7] Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy
    Breccia, Massimo
    Lo-Coco, Francesco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) : 225 - 234
  • [8] Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
    Piccaluga, PP
    Martinelli, G
    Rondoni, M
    Malagola, M
    Gaitani, S
    Isidori, A
    Bonini, A
    Gugliotta, L
    Luppi, M
    Morselli, M
    Sparaventi, G
    Visani, G
    Baccarani, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1791 - 1795
  • [9] Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia
    Lang, K
    Menzin, J
    Earle, CC
    Mallick, R
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (10) : 941 - 948
  • [10] Combination of all-trans-retinoic acid and gemtuzumab ozogamicin in an elderly patient with acute promyelocytic leukemia and severe cardiac failure
    Finizio, O.
    Pezzullo, L.
    Rocco, S.
    Bene, L.
    De Rosa, C.
    Nunziata, G. R.
    Mettivier, V.
    ACTA HAEMATOLOGICA, 2007, 117 (03) : 188 - 190
12345